Obesity and Diabetes

Patients with type 2 diabetes are obese, and the global epidemic of obesity, its incidence and prevalence of type 2 diabetes over the past 20 years has given glance of diabetes in recent times. Excess weight is the main risk factor for type 2 diabetes, most of the obese individuals do not develop type 2 diabetes. Recent studies have identified relation between obesity and type 2 diabetes as it involves proinflammatory cytokines (tumor necrosis factor and interleukin-6), insulin resistance, deranged fatty acid metabolism, and cellular processes such as mitochondrial dysfunction and endoplasmic reticulum stress. These interactions are complex, and each of the are unclearly defined. Further genetic studies may elucidate additional  pathophysiological pathways for obesity and diabetes and identify promising new treatment targets. As physicians frequently prescribe glucose lowering medications associated with weight gain, as it results in  glycemic control and body weight and  current therapeutic options need more consideration. The issue is particularly concentrating on the evidence that even modest weight reduction whether through lifestyle or behavioral interventions, obesity medications, or bariatric surgery can improve glycemic control and reduce diabetes risk.

  • Type-2 Diabetes
  • Nutritional Therapy
  • Role of Hyperinsulinism
  • Obesity and Adipose Tissue Biology
  • Normal Insulin Sensitivity
  • Obesity Dependent Diabetes: Treatment

Related Conference of Obesity and Diabetes

March 13-14, 2025

8th International Conference on Obesity and Chronic Diseases

Prague, Czech Republic
March 24-25, 2025

27th Global Obesity Meeting

London, UK
April 17-18, 2025

5th World Summit on Obesity and Weight Management

Madrid, Spain
June 02-03, 2025

21st Euro Obesity and Endocrinology Congress

Amsterdam, Netherlands

Obesity and Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in